0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Colorectal Cancer Protection by Endoscopic and NSAID Combination

Gareth P. Morgan, MD
Arch Intern Med. 1996;156(8):910. doi:10.1001/archinte.1996.00440080112015.
Text Size: A A A
Published online

I read with great optimism the case-control study by Müller and Sonnenberg.1 They impressively reported a 5-year protective effect of diagnostic largebowel endoscopy on colorectal cancer mortality of approximately 60%. To ascribe protection to endoscopy alone, cases were noted if there was a possibility of nonsteroidal anti-inflammatory drug (NSAID) use, since NSAID consumption appears to reduce the risk of fatal colorectal cancer. For the purpose of the study, this was a necessary precaution. It is possible, however, that the combination of large-bowel endoscopy and NSAIDs could synergistically reduce the risk of fatal colorectal cancer.

Many patients receiving large-bowel endoscopy will have increased risks of colorectal cancer. The study by Müller and Sonnenberg suggests that the combination of endoscopy and polypectomy can arrest the polypcancer sequence. There is good evidence that treatment with NSAIDs can also arrest this sequence.2,3 Perhaps the combination of endoscopy and NSAIDs could form the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();